Tribe investors are requesting meetings with these issuers
PLEASE Add momentum by clicking each name OF INTEREST to request THAT WE SCHEDULE an event OR EVENTS SOON!
InMed Pharmaceuticals is a publicly traded clinical-stage company that trades on the Nasdaq under the symbol INM. InMed is developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN), in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. InMed employs a highly scientific approach to designing and developing medicines, which will help unlock the full potential of cannabinoid pharmaceuticals. InMed employs a highly scientific approach with a proven management team with a track record of success to designing and developing medicines, which will help unlock the full potential of cannabinoid pharmaceuticals.
INVO Bioscience (NASDAQ: INVO)
A medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Their solution, the INVO® Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience at a significantly lower cost than traditional IVF,.
GeoVax Labs., Inc. (NASDAQ: GOVX)
A clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform.
Chinook Therapeutics, Inc. (Nasdaq: KDNY)
A biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases
INmune Bio, Inc. (Nasdaq: INMB)
A clinical stage immunology company that is exclusively focused on modulating components of the Innate Immune system to treat diseases.
A Biotechnology firm that has developed a modular antisense peptide nucleic acid (PNA) platform with the capability to address rare genetic disease caused by mutant proteins with a single, cohesive approach.
NASDAQ: NBSE
Atossa Therapeutics, inc.
A clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19.
NASDAQ: ATOS
hecla mining
Engaged in discovering, acquiring, developing and producing silver, gold, lead and zinc in North America.
NYSE: HL
silvercorp metals
Engages in the acquisition, exploration, development, and mining of precious and base metal mineral properties in China.
NYSE: SVM
First Majestic silver corp.
Silver producer in Mexico pursuing the development of its existing mineral property assets.
NYSE: AG
Central garden & pet co.
Produces and distributes products for the lawn and garden, and pet supplies markets.
NASDAQ: CENT
You can also submit your own list of tickers here!